Notice of Intent to Sole Source - Development and Validation of Diagnostic Methods for Coccidioidomycosis (Valley Fever)

Inactive on SAM.gov — responses were due 29 Jul 2026 · Small Business Set Aside - Total · Centers for Disease Control and Prevention (CDC), HHS · Tucson, AZ · NAICS 541715 · Solicitation Notice_of_Intent_to_Sole_Source_Development_and_Validation_of_Diagnostic_Methods_for_Coccidioidomycosis_(Valley_Fever)

Following NAICS 541715? Get new solicitations in it by email as they post — no account needed.

Email me new ones

What happened next

SAM.gov marked this notice inactive — responses were due 29 July 2026.

No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.

Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.

Solicitation details

Solicitation numberNotice_of_Intent_to_Sole_Source_Development_and_Validation_of_Diagnostic_Methods_for_Coccidioidomycosis_(Valley_Fever)
Notice ID1df7bbf0cd7f4da1b92b4be25e8a4942
AgencyDepartment of Health and Human Services (HHS)
Sub-agencyCenters for Disease Control and Prevention (CDC)
Contracting officeCDC OFFICE OF ACQUISITION SERVICES
NAICS code541715 — Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology)
Product / service code (PSC)AN12
Set-asideSmall Business Set Aside - Total
Notice typeSpecial Notice
Posted15 July 2026
Response deadline29 July 2026 (closed)
Place of performanceTucson, AZ, USA

Get new NAICS 541715 solicitations by email

This one has closed. We'll email you when new NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology)) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.

Description

Notice of Intent to Sole Source - Development and Validation of Diagnostic Methods for Coccidioidomycosis (Valley Fever) The Centers for Disease Control and Prevention intends to award a sole source firm fixed price to Valley fever Solutions, INC, Valley Fever Center for Excellence (University of Arizona) to support the development, evaluation, and validation of diagnostic methods for coccidioidomycosis through collaboration with the Valley Fever Center for Excellence (VFCE). This project will leverage VFCE s existing biospecimen repository and clinical infrastructure to support diagnostic assay development. Additional specimen collection and enhanced storage capacity will be implemented to support expanded research needs. Product or Service Code: AN12 Health R&D Services; Applied Research NAICS Code: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) The anticipated period of performance is September 30, 2026, to September 29, 2027 Place of Performance: All work under this contract shall be performed at the contractor s facilities, specifically the Valley Fever Center for Excellence (VFCE), located within the United States. No work will be performed at CDC facilities. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received prior to the date and time below will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to Contract Specialist at dwb7@cdc.gov by 11:00AM (ET) on 07/29/2026.

Go deeper on this solicitation

FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.

Open the AI analysis in FedSift →

Free forever plan — no credit card. Browse solicitations without an account; sign in for AI analysis and matching.

Market context: HHS and NAICS 541715

About the buyer and the industry, not this specific solicitation. Source: USASpending.gov award data, updated nightly.

  • In fiscal year 2026, HHS obligated $406.8M across 212 contract actions under NAICS 541715.
  • 319 contracts worth $3.8B in this category end within the next 18 months.

HHS contracts under NAICS 541715 →

Other open solicitations in NAICS 541715

All NAICS 541715 solicitations →

More from Department of Health and Human Services

All HHS solicitations →

Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.

FedSift turns SAM.gov and USASpending data into federal BD intelligence — smart matches, recompete radar, cited AI solicitation analysis and compliance matrices.

Source data: SAM.gov (solicitations) and USASpending.gov (awards), refreshed nightly. FedSift is not affiliated with the U.S. Government.

Pricing · Privacy · Terms · support@fedsift.app